Evidence map›Paper›PMID 37490523›Full record

ArticleInternal medicine journal2023

Associations between symptoms and functional capacity in patients after COVID-19 infection and community controls.

Quan Huynh, Noah Wexler, Joel Smith, Leah Wright, Felicia Ho, Richard Allwood, Yusuke Sata, Stefano Manca, Erin Howden, Thomas H Marwick

Abstract read
In one paragraph

Article in Internal medicine journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Observational
  2. Article
  3. Observational
  4. Observational
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Quan HuynhImaging Research Laboratory, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
Noah WexlerImaging Research Laboratory, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
Joel SmithImaging Research Laboratory, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.ORCID 0000-0003-4227-6577
Leah WrightImaging Research Laboratory, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
Felicia HoImaging Research Laboratory, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
Richard AllwoodImaging Research Laboratory, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
Yusuke SataImaging Research Laboratory, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
Stefano MancaImaging Research Laboratory, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
Erin HowdenImaging Research Laboratory, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
Thomas H MarwickImaging Research Laboratory, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.ORCID 0000-0001-9065-0899

Funding

Wellcome Trust 105282
6 · The paper itself

Abstract

backgroundPost-acute sequelae of COVID-19 (PASC or 'long COVID') reflect ongoing symptoms, but these are non-specific and common in the wider community. Few reports of PASC have been compared with a control group.

aimsTo compare symptoms and objective impairment of functional capacity in patients with previous COVID-19 infection with uninfected community controls.

methodsIn this community-based, cross-sectional study of functional capacity, 562 patients from Western Melbourne who had recovered from COVID-19 infections in 2021 and 2022 were compared with controls from the same community and tested for functional capacity pre-COVID-19. Functional impairment (<85% of the predicted response) was assessed using the Duke Activity Status Index (DASI) and 6-min walk distance (6MWD) test. A subgroup underwent cardiopulmonary exercise testing before and after exercise training.

resultsOf 562 respondents (age 54 ± 12 years, 69% women), 389 were symptomatic. Functional impairment (<85% predicted metabolic equivalent of tasks) was documented by DASI in 149 participants (27%), and abnormal 6MWD (<85% predicted) was observed in 14% of the symptomatic participants. Despite fewer risk factors and younger age, patients with COVID-19 had lower functional capacity by 6MWD (P < 0.001) and more depression (P < 0.001) than controls. In a pilot group of seven participants (age 58 ± 12 years, two women, VO

conclusionsAlthough most participants (69%) had symptoms consistent with long COVID, significant subjective functional impairment was documented in 27% and objective functional impairment in 14%. An exercise training programme might be beneficial for appropriately selected patients.

Indexed as

COVID-19Post-Acute COVID-19 SyndromeAdultAgedCross-Sectional StudiesExerciseExercise TestExercise ToleranceFemaleHumansMaleMiddle Agedcardiorespiratory fitnessechocardiographyexercise capacityexercise traininglong COVID

Identifiers

PMID37490523
PMCPMC10947235

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.